Literature DB >> 8105630

Repeated treatment with lidocaine/prilocaine cream (EMLA) as a topical anaesthetic for the cleansing of venous leg ulcers. A controlled study.

C Hansson1, J Holm, S Lillieborg, A Syrén.   

Abstract

Repeated topical analgesia with EMLA 5% cream prior to the cleansing of venous leg ulcers was studied. Patients were randomly allocated to a series of 8 treatments with EMLA (n = 22) or to a control group (n = 21). A thick layer of the cream was applied to the ulcers for 30 min. At each of the 8 treatments, local reactions were assessed on a 4-point scale and pain from ulcer cleansing on a visual analogue scale. At the first and the last treatment the area of the ulcer was determined by mapping, a sample for a bacterial culture was taken and the amount of dead tissue, slough and granulation tissue present was assessed. Treatment with EMLA for 30 min significantly decreased the pain from cleansing of the leg ulcers and the frequency of post-cleansing pain. The analgesic effect remained unchanged with successive treatments. Repeated treatment with EMLA in leg ulcers would appear to be safe, as indicated by the absence of any serious untoward events. No statistically significant differences in local reactions or adverse effects on granulation tissue, ulcer area or bacterial flora were observed in the EMLA-treated patients compared with the control patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105630     DOI: 10.2340/000155555573231233

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers.

Authors:  F Dámaso Fernández-Ginés; Manuel Cortiñas-Sáenz; Desirée Agudo-Ponce; Ana Navajas-Gómez de Aranda; José A Morales-Molina; Carmen Fernández-Sánchez; Francisco Sierra-García; Héctor Mateo-Carrasco
Journal:  Int Wound J       Date:  2019-11-25       Impact factor: 3.315

Review 2.  Interactive wound dressings. A practical guide to their use in older patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

3.  Innovative pain management solutions in animals may provide improved wound pain reduction during debridement in humans: An opinion informed by veterinary literature.

Authors:  Christopher D Roberts; Peter A Windsor
Journal:  Int Wound J       Date:  2019-04-01       Impact factor: 3.315

4.  EMLA and Lidocaine Spray: A Comparison for Surgical Debridement in Venous Leg Ulcers.

Authors:  Roberto Cuomo; Carlo D'Aniello; Luca Grimaldi; Giuseppe Nisi; Gaia Botteri; Irene Zerini; Cesare Brandi
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

5.  EMLA anaesthetic cream for debridement of burns: a study of plasma concentrations of lidocaine and prilocaine and a review of the literature.

Authors:  Stefan Lillieborg; Leif Aanderud
Journal:  Int J Burns Trauma       Date:  2017-10-25

6.  Analgesic efficacy of equimolar 50% nitrous oxide/oxygen gas premix (Kalinox®) as compared with a 5% eutectic mixture of lidocaine/prilocaine (EMLA®) in chronic leg ulcer debridement.

Authors:  Juerg Traber; Ulrike Held; Maria Signer; Tobias Huebner; Stefan Arndt; Thomas A Neff
Journal:  Int Wound J       Date:  2016-08-08       Impact factor: 3.315

Review 7.  Optimal treatment of venous (stasis) ulcers in elderly patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

8.  Topical EMLA Cream as a Pretreatment for Facial Lacerations.

Authors:  Sung Woo Park; Tae Suk Oh; Jong Woo Choi; Jin Sup Eom; Joon Pio Hong; Kyung S Koh; Taik Jong Lee; Eun Key Kim
Journal:  Arch Plast Surg       Date:  2015-01-14

Review 9.  Topical agents or dressings for pain in venous leg ulcers.

Authors:  Michelle Briggs; E Andrea Nelson; Marrissa Martyn-St James
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

10.  Eutectic mixture of local anaesthetics (EMLA®) as a primary dressing on painful chronic leg ulcers: a pilot randomised controlled trial.

Authors:  Anne Purcell; Thomas Buckley; Jennie King; Wendy Moyle; Andrea P Marshall
Journal:  Pilot Feasibility Stud       Date:  2018-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.